دورية أكاديمية

1752P Post hoc analysis of pembrolizumab efficacy in potentially platinum ineligible patients with urothelial carcinoma enrolled in KEYNOTE-052 and LEAP-011

التفاصيل البيبلوغرافية
العنوان: 1752P Post hoc analysis of pembrolizumab efficacy in potentially platinum ineligible patients with urothelial carcinoma enrolled in KEYNOTE-052 and LEAP-011
المؤلفون: Loriot, Y., Csoszi, T., Matsubara, N., Shin, S.J., Park, S.H., Atduev, V., Gumus, M., Karaca, B.B., Grivas, P., De Wit, R., Siefker-Radtke, A.O., Castellano Gauna, D.E., O'Donnell, P.H., Powles, T.B., Vuky, J., Zhao, Y., O'hara, K., Franco, S., Homet Moreno, B., Zolnierek, J.
المصدر: In Annals of Oncology September 2022 33 Supplement 7:S1339-S1339
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09237534
DOI:10.1016/j.annonc.2022.07.1830